Thymosin Beta-4 is a naturally occurring protein
Schedule I lists drugs or other substance that have a high potential for abuse have no accepted medical use in the United States, and do not have accepted safety guidelines for use
Sureshan M, Prabhu D, Kadhirvel S (2022) Computational identification and experimental validation of anti-filarial lead molecules targeting metal binding/substrate channel residues of Cu/Zn SOD1 from Wuchereria bancrofti
Use it twice daily, morning and evening, after cleansing
Being eligible to compound does not mean the finished peptide product is FDA-approved the way a mass-market drug is, Dustin Robinson explains
Retatrutide activates GLP-1, GIP, and glucagon receptors, making it a triple agonist and the most receptor-diverse obesity compound currently in clinical development